This information was published on 2025-03-06T04:16:03 for IP Right Filed Published.
| Field | Value |
| (210) | 2527980 (IR 1842405) |
| (220) |
03 Feb 2025
|
| (300) |
US, 17 Sep 2024, 98755607
|
| (511) (510) |
Class 5
Gene therapy products used in the treatment of ocular diseases. Class 42 Gene therapy research; research, development, and testing of pharmaceutical preparations for gene therapy; research, development, and testing of pharmaceutical preparations for gene therapy for use in the treatment of ocular diseases. |
| (540) | ONE AND DONE |
| (550) | Word |
| (730) |
Adverum Technologies, Inc.
|
Find out more about publications on the About page.